Micro-Cap Brain Cancer Focused Plus Therapeutics Poised To Receive $3M From US Department of Defense

1 year ago 87

Plus Therapeutics will secure $3 million in funding from the Department of Defense for pediatric brain cancer trial expansion.

1. Homepage
2. Brain Cancer
3. Micro-Cap Brain Cancer Focused Plus Therapeutics Poised To Receive $3M From US Department of Defense